Stay updated on Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.7%
    Check dated 2024-07-26T17:08:15.000Z thumbnail image
  2. Check
    2 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-07-25T16:34:13.000Z thumbnail image
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, replacing the previous version v2.9.7.
    Difference
    0.5%
    Check dated 2024-07-23T14:33:02.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-07-20T10:23:38.000Z thumbnail image
  7. Check
    8 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-07-19T09:22:32.000Z thumbnail image
  8. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T06:28:13.000Z thumbnail image

Stay in the know with updates to Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.